Pancreatic Cancer Research

ResearcherWannan Medical CollegeActive in the last 2 years

Yan Jin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5957-7443; OpenAlex author ID A5000444143, A5121831089. Sources: OpenAlex.

Their work

Papers
12 (first author 1, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
24
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 2 papers · 2018: 2 papers · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 12

  1. Emerging role of interaction between m6A and main ncRNAs in pancreatic cancer. Last author DOI 10.1016/j.ctarc.2026.101270↗
  2. The lncRNA ST18-AS1 suppresses pancreatic cancer progression by enhancing ST18 mRNA stability through anchoring FUS in the cytoplasm. Co-author DOI 10.1038/s41388-025-03455-4↗
  3. The role of LncRNA-MANCR induced by HIF-1α drive the malignant progression of pancreatic cancer by targeting miRNA-494/SIRT1 signaling axis under hypoxic condi… Co-author DOI 10.1038/s41417-025-00900-0↗
  4. Cancer-associated fibroblast-derived exosome Leptin promotes malignant biological lineage in pancreatic ductal adenocarcinoma by regulating ABL2 via miR-224-3p. Co-author DOI 10.1007/s11033-024-09928-1↗
  5. LncRNA HOTAIR Promotes Cancer Stem-Like Cells Properties by Sponging miR-34a to Activate the JAK2/STAT3 Pathway in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.2147/ott.s286666↗
  6. Expression of miR-214 in pancreatic cancer and its effect on the biological function of pancreatic cancer cells. Last author PMID 34268979↗
  7. MiRNA-646-mediated reciprocal repression between HIF-1α and MIIP contributes to tumorigenesis of pancreatic cancer. First author DOI 10.1038/s41388-017-0082-2↗
  8. The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose. Co-author DOI 10.1038/s41419-017-0158-5↗
  9. ASIC1 and ASIC3 contribute to acidity-induced EMT of pancreatic cancer through activating Ca2+/RhoA pathway. Co-author DOI 10.1038/cddis.2017.189↗
  10. rs1859168 A > C polymorphism regulates HOTTIP expression and reduces risk of pancreatic cancer in a Chinese population. Last author DOI 10.1186/s12957-017-1218-0↗
  11. MiR-548an, Transcriptionally Downregulated by HIF1α/HDAC1, Suppresses Tumorigenesis of Pancreatic Cancer by Targeting Vimentin Expression. Co-author DOI 10.1158/1535-7163.mct-15-0877↗
  12. Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulated by miR-217-SIRT1 pathway. Co-author DOI 10.1016/j.canlet.2014.08.007↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gang Wang · 2 shared papers, 2025 · strength 0.47
  2. Shikang Deng · 2 shared papers, 2021 · strength 0.33
  3. Shi-Jiang Deng · 5 shared papers, 2014–2018 · strength 0.29
  4. Shichang Deng · 5 shared papers, 2014–2018 · strength 0.29
  5. Gang Zhao · 5 shared papers, 2014–2018 · strength 0.29
  6. Xiang Li · 5 shared papers, 2014–2018 · strength 0.29
  7. Shuai Zhu · 5 shared papers, 2014–2018 · strength 0.29
  8. Chunyou Wang · 5 shared papers, 2014–2018 · strength 0.29
  9. XingKai Rui · 1 shared paper, 2026 · strength 0.28
  10. Yilong Li · 1 shared paper, 2025 · strength 0.24
  11. Long Cheng · 1 shared paper, 2025 · strength 0.24
  12. Long Cheng · 1 shared paper, 2025 · strength 0.24
  13. Li Zhang · 1 shared paper, 2024 · strength 0.23
  14. Yun Jin · 1 shared paper, 2024 · strength 0.23
  15. Mingliang Liu · 3 shared papers, 2016–2018 · strength 0.19
  16. Li Zhang · 1 shared paper, 2021 · strength 0.17
  17. Zhu Zeng · 2 shared papers, 2016–2018 · strength 0.12
  18. Qi Qin · 2 shared papers, 2014–2018 · strength 0.11
  19. Pinghai Hu · 1 shared paper, 2017 · strength 0.08
  20. Ye Zeng · 1 shared paper, 2018 · strength 0.07
  21. Yi Niu · 1 shared paper, 2018 · strength 0.07
  22. Ming Yang · 1 shared paper, 2014 · strength 0.03
  23. Tao Yin · 1 shared paper, 2014 · strength 0.03
  24. Heshui Wu · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.